Thursday, May 23, 2019
Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
Related Posts:
Broadcasters group releases 30-second public-service spot with 10 seconds from Sen. Mitch McConnell promoting vaccination
Legislators wrestle with how to keep students in the classroom and at what age to require masks in day-care centers
2nd highest day for new cases; 2/3 of hospitals say staff critically short; Beshear says health system in state could be overwhelmed
Wed. was 3rd highest day for new coronavirus cases in Kentucky, and intensive-care units are filling up all over the state
Agenda for session includes aid for hospitals and nursing homes, and making it easier for doctors' offices to get and give vaccines
0 comments:
Post a Comment